REQUEST A DEMO
Total
USD $0.00
Search more companies

Dacapharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Dacapharma S.A.S. Profile Updated: May 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Dacapharma S.A.S. is based in Colombia, with the head office in Barranquilla. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on September 17, 2018. In 2024, the company reported a net sales revenue increase of 69.73%. Its’ total assets recorded a growth of 41.15%. The net profit margin of Dacapharma S.A.S. decreased by 1.65% in 2024.

Headquarters
Calle 74 # 48 - 34
Barranquilla; Atlantico;

Contact Details: Purchase the Dacapharma S.A.S. report to view the information.

Basic Information
Financial Auditors:
Purchase the Dacapharma S.A.S. report to view the information.
Incorporation Date:
September 17, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Dacapharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
69.73%
Total operating revenue
69.73%
Operating profit (EBIT)
-21.77%
Net Profit (Loss) for the Period
14.36%
Total Assets
41.15%
Total Equity
83.78%
Operating Profit Margin (ROS)
-10.09%
Net Profit Margin
-1.65%
Return on Equity (ROE)
-5.69%
Quick Ratio
405.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?